Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CCRe-IV: Primary Tumor Resection in Metastatic Colorectal Cancer
NCT02015923Phase 4Terminated
- Sponsor
- Bellvitge University Hospital
- Start
- Dec 2013
- Primary completion
- Jun 2019
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial (2 arms), sponsored by Bellvitge University Hospital. Primary endpoint: Overall Survival at 2 years. Started Dec 2013; status: terminated.
Beyond the preview
Go deeper on NCT02015923.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02015923.